People
Experienced core team and board
Built on decades of diabetes care experience
GO-Pen combines over 50 years of collective diabetes care expertise with diverse international perspectives. Our team spans insulin device innovation, regulatory excellence, global health access, and lived patient experience.
From Denmark to India, Tunisia, and Germany, we bring together seasoned leadership and fresh analytical insights—all united by our shared purpose of creating equal access to quality diabetes care globally.
Our team
-
Ole Kjerkegaard Nielsen
CEO & Co-Founder
Bringing 15+ years of diabetes care leadership from Novo Nordisk and global health equity expertise to democratize insulin delivery worldwide.
-
Michael Ejstrup Hansen
CTO & Co-Founder
Mechanical engineering innovator and co-inventor of multiple Novo Nordisk insulin device patents, bringing 25+ years of medical device development expertise to accessible diabetes technology.
-
Amin Zayani
Director, Product Management
Type 1 diabetes advocate and product development expert, combining lived experience with deep healthcare technology innovation from Novo Nordisk and EliLily partnerships.
-
Aparajita Tatke
Director, Regulatory Affairs and Quality Assurance
Pharmaceutical sciences expert leading GO-Pen's global regulatory strategy, instrumental in securing FDA clearance and ensuring worldwide market access for accessible diabetes technology.
-
Brit Larsen
Director of Communication
Strategic communication leader with 15+ years driving diabetes access initiatives at Novo Nordisk and World Diabetes Foundation, involved in numerous innovative global health partnerships.
-
Christian Christiansen
Senior Director of Operations
Medical device executive with 25+ years in engineering and operations. CEO of Nordic NeuroSTIM and MEDODAN. Expert in clinical testing, FDA/CE clearances, IP management, and international manufacturing. Proven track record scaling medical device startups globally.
-
Bijaya Chettri
Regulatory Affairs and Quality Assurance
Pharmaceutical sciences expert supporting GO-Pen's regulatory excellence through hands-on quality assurance experience and advanced pharmaceutical education from both Denmark and India.
-
Gustav Dahlgaard
Analyst
Economics student and data analysis specialist supporting GO-Pen's strategic growth through analytical insights and business intelligence during the company's critical market expansion phase.
Our partners
We are teaming up with a range of talented and highly experienced people on our journey towards developing an affordable insulin pen for all
Contract development of medical experience
Board of Directors
-
Chair of the Board
Biotech executive with 15+ exits and 2 IPOs. CEO of Synact Pharma, took company public on Nasdaq Stockholm. Extensive experience scaling healthcare companies across Nordic markets and international expansion.
-
Board Director, Co-Founder
Mechanical engineer and co-inventor of multiple Novo Nordisk insulin device patents. 25+ years developing medical devices from concept through FDA clearance. Expert in accessible diabetes technology innovation.
-
CEO/CFO, Co-Founder
Healthcare innovation leader with extensive Novo Nordisk experience and field work in emerging markets. Specializes in sustainable healthcare solutions and developing market strategies for accessible diabetes care.
-
Board member
Biotech CEO and board member with extensive life sciences leadership experience. Former CEO of Immudex and current CEO of Furine ApS. Expert in regulatory affairs, drug development, and scaling biotech companies from early stage through commercialization, bringing strategic healthcare industry expertise.
-
Board member
Impact investor and entrepreneur specializing in tech-driven solutions for African markets. Co-founder of Carbory ApS and experienced board member across multiple startups. Brings strategic expertise in scaling businesses that address global health challenges while creating sustainable social and environmental impact.
-
Board member
CEO of AJ Vaccines serving 50+ countries through WHO/UNICEF partnerships. 25+ years pharmaceutical leadership including €500M+ international expansion. Expert in global healthcare market operations.
Advisory Board
-
CEO of Diabetes Center Berne and General Partner at Swiss Diabetes Venture Fund. Entrepreneurial leader with extensive pharma, biotech, and medical device expertise. Focuses on diabetes technology innovation and patient-centered business strategies, bringing deep industry knowledge and investment experience to diabetes care development.
-
Partner at Horten law firm specializing in intellectual property litigation and regulatory matters within Life Sciences. Expert in patent strategy, commercialization of IP rights, and complex regulatory compliance for startups to major companies, particularly in pharmaceuticals and medical devices.
-
Former Corporate Vice President at Novo Nordisk with PhD in medicinal chemistry. 35+ years pharmaceutical industry experience spanning drug development, protein chemistry, and medical devices. Senior advisor and mentor specializing in life science startup development and regulatory strategy.